Skip to main navigation Skip to search Skip to main content

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

  • Shinsuke Iida
  • , Takayuki Ishikawa
  • , Chang Ki Min
  • , Kihyun Kim
  • , Su Peng Yeh
  • , Saad Z. Usmani
  • , Maria Victoria Mateos
  • , Hareth Nahi
  • , Christoph Heuck
  • , Xiang Qin
  • , Dolly A. Parasrampuria
  • , Katharine S. Gries
  • , Ming Qi
  • , Nizar Bahlis
  • , Shigeki Ito
  • Nagoya City University
  • Kobe City Medical Center General Hospital
  • The Catholic University of Korea
  • China Medical University Taichung
  • Levine Cancer Institute/Atrium Health
  • Hospital Clínico Universitario de Salamanca
  • Karolinska Institutet
  • Johnson & Johnson
  • University of Calgary
  • Iwate Medical University

Research output: Contribution to journal › Article › peer-review

6   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science